Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2025-12-24 @ 9:49 PM
NCT ID:
NCT05813132
Eligibility Criteria:
Inclusion Criteria
1\. Patients with lymphoma relapsed/refractory (RR) Hodgkin's lymphoma (HL) and non-Hodgkin lymphoma (NHL) with all subtypes. 2. Treat with conventional dose salvage regimens 3. Remission status before HSCT is complete remission (CR) or partial remission (PR).
4\. Age\>18 years. 5. Gender male and female. 6. CD34+ count cells \<2 ×106 CD34+ cells/kg BW. Exclusion Criteria
1. Remission status before HSCT is non remission (NR) or progressive disease (PD).
2. CD34+ count cells \<2 ×106 CD34+ cells/kg BW
3. CNS lymphoma or solid tumor not included in population.
4. Pregnancy or breast-feeding.
5. Any Psychological, familial, sociological, or geographical factor that interfere with patient adherence to medications.
6. History of allergy to any medications in both protocol
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT05813132
Study Brief:
Protocol Section:
NCT05813132